ID: ALA196028

Max Phase: Preclinical

Molecular Formula: C13H11NOS

Molecular Weight: 229.30

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1cc2c3sc(=O)ccc3ccc2n1C

Standard InChI:  InChI=1S/C13H11NOS/c1-8-7-10-11(14(8)2)5-3-9-4-6-12(15)16-13(9)10/h3-7H,1-2H3

Standard InChI Key:  LCEIAFMDZYSWDE-UHFFFAOYSA-N

Associated Targets(Human)

HL-60 67320 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

LoVo 4724 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Jurkat 10389 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HT-1080 3966 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Ribonuclease pancreatic 45 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Serum albumin 1163 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 229.30Molecular Weight (Monoisotopic): 229.0561AlogP: 3.06#Rotatable Bonds: 0
Polar Surface Area: 22.00Molecular Species: HBA: 3HBD: 0
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 2.96CX LogD: 2.96
Aromatic Rings: 3Heavy Atoms: 16QED Weighted: 0.58Np Likeness Score: -0.74

References

1. Barraja P, Sciabica L, Diana P, Lauria A, Montalbano A, Almerico AM, Dattolo G, Cirrincione G, Disarò S, Basso G, Viola G, Dall'Acqua F..  (2005)  Synthesis and photochemotherapeutic activity of thiopyrano[2,3-e]indol-2-ones.,  15  (9): [PMID:15837311] [10.1016/j.bmcl.2005.03.016]
2. Barraja P, Diana P, Montalbano A, Carbone A, Cirrincione G, Viola G, Salvador A, Vedaldi D, Dall'acqua F..  (2008)  Thiopyrano[2,3-e]indol-2-ones: angelicin heteroanalogues with potent photoantiproliferative activity.,  16  (22): [PMID:18951030] [10.1016/j.bmc.2008.10.002]

Source